OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Timo Myöhänen

1 Projects | 1 Researchers | $282,600 Invested

2024

Polku Therapeutics

Timo Myöhänen, PhD

Novel prolyl oligopeptidase ligands to target Tau in frontotemporal dementia and other tauopathies

  • Funding Amount: $282,600
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Tau
  • Status: Active